NCT03435744View on ClinicalTrials.gov

Simvastatin as an Augmentation Treatment for Treatment Resistant Depression: Randomized Controlled Trial.

PHASE3CompletedINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

January 1, 2019

Primary Completion Date

June 30, 2021

Study Completion Date

June 30, 2021

Conditions
Treatment Resistant DepressionMajor Depressive Disorder
Interventions
DRUG

Simvastatin 20 mg

Simvastatin 20 mg added to TAU for 3 months.

OTHER

Placebo Oral Tablet

Matched placebo added to TAU for 3 months

Trial Locations (4)

75500

Civil Hospital, Karachi

Unknown

Civil Hospital, Hyderābād

Abbasi Shaheed Hospital, Karachi

Institute of Professional Psychology, Rawalpindi

All Listed Sponsors
collaborator

King's College London

OTHER

lead

Pakistan Institute of Living and Learning

OTHER

NCT03435744 - Simvastatin as an Augmentation Treatment for Treatment Resistant Depression: Randomized Controlled Trial. | Biotech Hunter | Biotech Hunter